Data / Form D filings / Origin Endoscopy Inc.
Origin Endoscopy Inc.: Form D filings
Origin Endoscopy Inc., a biotechnology company in Englewood, CO, filed 3 Form D notices with the SEC between 2024 and 2025. The latest, on June 10, 2025, reports $2.3 million sold of a $2.6 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9800 PYRAMID CT, SUITE 400, Englewood, CO, 80112
- Phone
- (720) 772-0631
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2039132
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 10, 2025 | Amendment | $2,639,279 | $2,340,326 | $298,953 | 5 | Sep 18, 2024 | sec.gov |
| Oct 3, 2024 | Amendment | $1,590,329 | $1,590,329 | 3 | Sep 18, 2024 | sec.gov | |
| Sep 27, 2024 | New notice | $950,000 | $950,000 | 3 | Sep 18, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Freeman | Director | |
| Jason Ylizarde | Executive Officer | |
| Jason Grimes | Director | |
| Jeremy Starkweather | Executive Officer, Director | |
| John Wynne | Executive Officer, Director | |
| Stephen Hoag | Director |
Other biotechnology companies in Colorado that filed recently
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
- Shiverbright Technologies, Inc. $200,000 · Aug 7, 2026
Every Form D from the week of Jun 9, 2025 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Origin Endoscopy Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.